-
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
12 Nov 2024 21:45 GMT
… Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS …
(6,082
)
Basic and diluted earnings per common share:
Net loss …
-
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
14 Aug 2024 20:05 GMT
… Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved … trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
… (5,498
)
Basic and diluted earnings per common share:
…
-
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q2 2024 Earnings Call Transcript
15 Aug 2024 13:28 GMT
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q2 2024 Earnings Call Transcript August 14, 2024
… day. Goodbye.
Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC …
-
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
14 May 2024 20:05 GMT
… of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC … ,854
)
Basic and diluted earnings per common share:
…
835,946
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED BALANCE SHEET
(In …
-
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2024 Earnings Call Transcript
15 May 2024 12:17 GMT
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2024 Earnings Call Transcript May 14, 2024
… ;A Session Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC …
-
CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023
20 Mar 2024 01:44 GMT
Source: iQoncept / Shutterstock
Cyclacel Pharmaceuticals (NASDAQ:CYCC) just reported … the fourth quarter of 2023.
Cyclacel Pharmaceuticals reported earnings per share of -$6 … #47;03/cycc-stock-earnings-cyclacel-pharmaceuticals-for-q4-of-2023…
-
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
19 Mar 2024 20:05 GMT
… Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS …
(21,399
)
Basic and diluted earnings per common share:
Net loss …
-
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
20 Mar 2024 00:04 GMT
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 Earnings Call Transcript March 19, 2024 … to the Cyclacel Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Conference Call … quarter and full year 2023 earnings call. Cyclacel has achieved a …
-
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated by Analysts at StockNews.com
28 Jan 2024 12:34 GMT
… .
Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) last issued its quarterly earnings data … analysts anticipate that Cyclacel Pharmaceuticals will post -27.16 earnings per share for …
-
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com
20 Jan 2024 11:21 GMT
… Our Latest Stock Report on Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals Stock Performance
Want More Great … .65.
Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) last released its earnings results …
About
© 1995-2025